NO20010802L - Nye aryl- eller heteroarylkinolylfosfonsyreforbindelser, en fremgangsmåte ved deres fremstilling og sammensetningerinneholdende dem - Google Patents

Nye aryl- eller heteroarylkinolylfosfonsyreforbindelser, en fremgangsmåte ved deres fremstilling og sammensetningerinneholdende dem

Info

Publication number
NO20010802L
NO20010802L NO20010802A NO20010802A NO20010802L NO 20010802 L NO20010802 L NO 20010802L NO 20010802 A NO20010802 A NO 20010802A NO 20010802 A NO20010802 A NO 20010802A NO 20010802 L NO20010802 L NO 20010802L
Authority
NO
Norway
Prior art keywords
heteroarylquinolylphosphonic
preparation
compositions containing
acid compounds
new aryl
Prior art date
Application number
NO20010802A
Other languages
English (en)
Other versions
NO20010802D0 (no
Inventor
Alex Cordi
Patrice Desos
Pierre Lestage
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO20010802D0 publication Critical patent/NO20010802D0/no
Publication of NO20010802L publication Critical patent/NO20010802L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/60Quinoline or hydrogenated quinoline ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Forbindelser med formel (I) : hvori : > R1 representerer et halogenatom eller en gruppe CF3, > R2 representerer en aryl- eller heteroarylgruppe, > R3 og R4 er som definert i beskrivelsen. Medikamenter.
NO20010802A 2000-02-18 2001-02-16 Nye aryl- eller heteroarylkinolylfosfonsyreforbindelser, en fremgangsmåte ved deres fremstilling og sammensetningerinneholdende dem NO20010802L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0002013A FR2805262A1 (fr) 2000-02-18 2000-02-18 Nouveaux derives d'acides aryle ou heteroaryle quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO20010802D0 NO20010802D0 (no) 2001-02-16
NO20010802L true NO20010802L (no) 2001-08-20

Family

ID=8847124

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010802A NO20010802L (no) 2000-02-18 2001-02-16 Nye aryl- eller heteroarylkinolylfosfonsyreforbindelser, en fremgangsmåte ved deres fremstilling og sammensetningerinneholdende dem

Country Status (23)

Country Link
US (1) US6420386B1 (no)
EP (1) EP1125940B1 (no)
JP (1) JP2001278890A (no)
KR (1) KR20010082704A (no)
CN (1) CN1317489A (no)
AR (1) AR027431A1 (no)
AT (1) ATE231154T1 (no)
AU (1) AU2303901A (no)
BR (1) BR0100600A (no)
CA (1) CA2337301A1 (no)
DE (1) DE60100080T2 (no)
DK (1) DK1125940T3 (no)
EA (1) EA200100157A3 (no)
ES (1) ES2190426T3 (no)
FR (1) FR2805262A1 (no)
HK (1) HK1039943A1 (no)
HU (1) HUP0100751A3 (no)
MX (1) MXPA01001559A (no)
NO (1) NO20010802L (no)
NZ (1) NZ510003A (no)
PL (1) PL345917A1 (no)
SI (1) SI1125940T1 (no)
ZA (1) ZA200101337B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805260A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-sulfamoyl-3-quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPWO2010035745A1 (ja) 2008-09-25 2012-02-23 杏林製薬株式会社 ヘテロ環ビアリール誘導体及びそれらを有効成分とするpde阻害剤
JPWO2010041711A1 (ja) * 2008-10-09 2012-03-08 杏林製薬株式会社 イソキノリン誘導体及びそれらを有効成分とするpde阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683818B1 (fr) * 1991-11-14 1993-12-31 Adir Cie Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5342946A (en) * 1992-12-02 1994-08-30 Guilford Pharmaceuticals Inc. Phosphonoalkylquinolin-2-ones as novel antagonists of non-NMDA ionotropic excitatory amino acid receptors
FR2709489B1 (fr) * 1993-08-31 1995-10-20 Adir Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2750988B1 (fr) * 1996-07-11 1998-09-18 Adir Nouveaux derives de 2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
EA200100157A3 (ru) 2001-10-22
PL345917A1 (en) 2001-08-27
ATE231154T1 (de) 2003-02-15
HUP0100751A3 (en) 2002-09-30
SI1125940T1 (en) 2003-04-30
CA2337301A1 (fr) 2001-08-18
EP1125940A1 (fr) 2001-08-22
BR0100600A (pt) 2001-09-18
EA200100157A2 (ru) 2001-08-27
HUP0100751A2 (hu) 2002-01-28
JP2001278890A (ja) 2001-10-10
NZ510003A (en) 2001-09-28
HU0100751D0 (en) 2001-04-28
DE60100080T2 (de) 2003-11-20
CN1317489A (zh) 2001-10-17
US6420386B1 (en) 2002-07-16
AR027431A1 (es) 2003-03-26
KR20010082704A (ko) 2001-08-30
ZA200101337B (en) 2001-08-21
DE60100080D1 (de) 2003-02-20
DK1125940T3 (da) 2003-05-05
HK1039943A1 (zh) 2002-05-17
ES2190426T3 (es) 2003-08-01
AU2303901A (en) 2001-08-23
MXPA01001559A (es) 2002-08-06
NO20010802D0 (no) 2001-02-16
FR2805262A1 (fr) 2001-08-24
EP1125940B1 (fr) 2003-01-15

Similar Documents

Publication Publication Date Title
NO20054329L (no) Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike
NO20054787L (no) Indenderivater som farmasotiske midler
NO20055688L (no) Organiske forbindelser
SE9904652D0 (sv) Novel Compounds
DK1206467T3 (da) N-heterocykliske derivater som NOS-inhibitorer
NO20062491L (no) Benzoksazinderivter og deres anvendelse
NO20076006L (no) Acetylenderivater
NO20066055L (no) Pyridinderivater
NO20051047L (no) Fremgangsmate og mellomprodukter for fremstilling av tienopyrrolderivater
NO20050635L (no) Nye tricykliske spiropiperidiner eller spiropyrrolidiner
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
DK1295890T3 (da) Hidtil ukendte pyrazinderivater eller salte deraf, farmaceutiske præparater, der indeholder derivaterne eller saltene, og mellemprodukter til fremstilling af begge
NO20030301L (no) Nye heteroarylderivater og anvendelse derav som farmasöytika
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav
NO20070570L (no) Forbindelser.
NO983493L (no) Nye benzimidazol-, benzoksazol- og benzotiazolforbindelser, fremgangsmÕte ved fremstilling derav og farmas°ytiske sammensetninger inneholdende slike
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav
NO20061045L (no) Imidazolderivater
NO20060718L (no) Substituerte tiofoner og deres anvendelse
NO20076000L (no) Aminosyrederivater
NO20074346L (no) Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20060258L (no) Nematicidale tiazolin-inneholdende fluorobutener
NO20023251L (no) Nye tetrahydropyridiner, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application